Dailey Tamara A, Woodruff John H, Dailey Harry A
Department of Microbiology, Biomedical and Health Sciences Institute, University of Georgia, Athens, GA 30602-7229, USA.
Biochem J. 2005 Mar 1;386(Pt 2):381-6. doi: 10.1042/BJ20040570.
The initial and the terminal three enzymes of the mammalian haem biosynthetic pathway are nuclear encoded, cytoplasmically synthesized and post-translationally translocated into the mitochondrion. The first enzyme, ALAS (5-aminolaevulinate synthase), occurs as an isoenzyme encoded on different chromosomes and is synthesized either as a housekeeping protein (ALAS-1) in all non-erythroid cell types, or only in differentiating erythroid precursor cells (ALAS-2). Both ALAS proteins possess mitochondrial targeting sequences that have putative haem-binding motifs. In the present study, evidence is presented demonstrating that two haem-binding motifs in the leader sequence, as well as one present in the N-terminus of the mature ALAS-1 function in vivo in the haem-regulated translocation of ALAS-1. Coproporphyrinogen oxidase, the antepenultimate pathway enzyme, possesses a leader sequence that is approx. 120 residues long. In contrast with an earlier report suggesting that only 30 residues were required for translocation of the coproporphyrinogen oxidase, we report that the complete leader is necessary for translocation and that this process is not haem-sensitive in vivo. PPO (protoporphyrinogen oxidase) lacks a typical mitochondrial targeting leader sequence and was found to be effectively targeted by just 17 N-terminal residues. Bacillus subtilis PPO, which is very similar to human PPO at its N-terminal end, is not targeted to the mitochondrion when expressed in mammalian cells, demonstrating that the translocation is highly specific with regard to both the length and spacing of charged residues in this targeting region. Ferrochelatase, the terminal enzyme, possesses a typical N-terminal leader sequence and no evidence of a role for the C-terminus was found in mitochondrial targeting.
哺乳动物血红素生物合成途径的起始和终末三种酶是由核基因编码,在细胞质中合成,然后经翻译后转运到线粒体中。第一种酶,δ-氨基-γ-酮戊酸合酶(ALAS),以同工酶形式存在,由不同染色体编码,在所有非红细胞类型中作为管家蛋白(ALAS-1)合成,或仅在分化的红细胞前体细胞中合成(ALAS-2)。两种ALAS蛋白都具有线粒体靶向序列,这些序列具有假定的血红素结合基序。在本研究中,有证据表明,前导序列中的两个血红素结合基序以及成熟ALAS-1的N端中的一个基序在体内对ALAS-1的血红素调节转运起作用。粪卟啉原氧化酶是该途径的倒数第二种酶,其前导序列约120个残基长。与早期报道表明粪卟啉原氧化酶转运仅需30个残基相反,我们报道完整的前导序列对于转运是必需的,并且该过程在体内对血红素不敏感。原卟啉原氧化酶(PPO)缺乏典型的线粒体靶向前导序列,发现仅17个N端残基就能有效地将其靶向。枯草芽孢杆菌PPO在其N端与人PPO非常相似,在哺乳动物细胞中表达时不会靶向线粒体,这表明转运对于该靶向区域中带电荷残基的长度和间距具有高度特异性。终末酶亚铁螯合酶具有典型 的N端前导序列,未发现C端在线粒体靶向中有作用的证据。